Press Release “Flash" radiotherapy: another step towards clinical applications for Institut Curie and SIT 05/04/2021 Partnership Institut Curie names Intel lead partner...05/23/2018 Partnership Institut Curie and Pierre Fabre initiate a novel partnership in immuno-oncology 10/20/2017 Partnership Servier and Institut Curie extend duration and scope of partnership09/05/2017 Iron-mediated cancer cell activity: a new regulation mechanism08/03/2020 Accelerating the pace of pediatric oncology research and innovating at Institut Curie, to better care for young patients09/15/2021 Corporate APPOINTMENT: Alain Puisieux, new director of Institut Curie Research Center09/02/2019 Intestinal Health : Macrophages lead the conversation between the microbiota and the colon10/19/2020 OncoDNA and Institut Curie test the clinical utility of personalized liquid biopsy in head and neck cancers04/16/2021 Cell multiplication : measuring up10/16/2020 LEBANON: Institut Curie steps up its support in oncology05/17/2021 Nanomedicine and new targeted therapies: the advances of Institut Curie at the ASCO 2021 Meeting06/10/2021
“Flash" radiotherapy: another step towards clinical applications for Institut Curie and SIT 05/04/2021
Partnership Institut Curie and Pierre Fabre initiate a novel partnership in immuno-oncology 10/20/2017
Accelerating the pace of pediatric oncology research and innovating at Institut Curie, to better care for young patients09/15/2021
OncoDNA and Institut Curie test the clinical utility of personalized liquid biopsy in head and neck cancers04/16/2021
Nanomedicine and new targeted therapies: the advances of Institut Curie at the ASCO 2021 Meeting06/10/2021
